Liabilities / Assets
Score unavailable
Liabilities-to-assets requires both liabilities and assets on the latest valid filing.
Peptide Therapeutics Foundation
EIN 26-3728931 • 501(c)3 • San Diego, CA
Profile
The mission of Peptide Therapeutics Foundation is to provide and promote public and charitable educational and information programs, materials, research and discussion in the the medical scientific field of peptide science and technology.
Siviq Scores
Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.
No value available
Liabilities / Revenue
Score unavailable
Liabilities-to-revenue requires both liabilities and revenue on the latest valid filing.
Net Margin
72nd percentile
Higher net margin than 72% of similar nonprofits.
Top Officer Pay
81st percentile
Higher top officer pay than 81% of similar nonprofits.
Top officer pay equals 0.0% of source-year revenue.
Asset Growth
74th percentile
Faster asset growth than 74% of similar nonprofits.
Revenue Growth
77th percentile
Faster revenue growth than 77% of similar nonprofits.
Balance Sheet
Assets
Up$335,263
Up $48,319 (+17%) from 2023
Liabilities
-
No earlier filing loaded for comparison.
Net Assets
Up$335,263
Up $48,319 (+17%) from 2023
Revenue
Up$174,477
Up $39,594 (+29%) from 2023
Expenses
Down$144,680
Down $13,223 (-8.4%) from 2023
Net Income
Up$29,797
Up $52,817 (+229%) from 2023
Trend Graphs
Filings
Most recent year
2024 • Form 990EZDetailed filing. Detailed filing data is available for this year.
- Assets
- $335,263
- Liabilities
- -
- Net assets
- $335,263
- Revenue
- $174,477
- Expenses
- $144,680
- Net income
- $29,797
Latest Filing Detail
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2024 to Dec 31, 2024
- Signed
- Jan 29, 2025
- Return Version
- 2024v5.0
- Gross Receipts
- $174,477
Mission and Program Overview
Mission
The mission of peptide therapeutics foundation is to provide and promote public and charitable educational and informational programs, materials, research and discussion in the medical scientific field of peptide science and technology.
The mission of Peptide Therapeutics Foundation is to provide and promote public and charitable educational and information programs, materials, research and discussion in the the medical scientific field of peptide science and technology.
Program Services
| Description | Grants | Expenses |
|---|---|---|
| see schedule O | $0 | $142,380 |
| All other accomplishment. Peptide therapeutics has assets in an brokerage firm. Expenses are related to the brokerage firm. | $0 | $2,300 |
Compensation and Service Providers
Employees
| Name | Title | Full / Part Time | Base | Other | Total |
|---|---|---|---|---|---|
| Phil Dawson PHD | Chairman Of Board | - | $0 | - | - |
| Adam Mezo PHD | President | - | $0 | - | - |
| Nick Cox PHD | Secretary | - | $0 | - | - |
| Adrienne DAy PH D | Treasurer & Board Administrator | - | $0 | - | - |
Filing and Contact Details
Filer
- Filer Name
- Peptide Therapeutics Foundation
- EIN
- 26-3728931
- Phone
- 8586571511
- Address
- 9395 Cabot Drive, San Diego, CA 92126
Signing Officer
- Name
- Adrienne Day PHD
- Title
- Treasurer&Board Director
- Phone
- 8586571511
- Signed
- 2025-01-29
- Discuss with paid preparer
- Yes
Preparer
- Firm
- V&r Associates
- Address
- 4616 Tarantella Lane, SD, CA 92130
- Preparer
- Viviane Hagopian
- Phone
- 6198848983
Supplemental Narrative
Additional Explanations
Pt III, Line 31
“All other accomplishment. Peptide therapeutics has assets in an brokerage firm. Expenses are related to the brokerage firm.”
Other
“Part III Line 28 Hold a peptide therapeutics symposium to bring together world leaders from academia, the biopharmaceutical industry, CMOS CROS,and investors interested in all aspects of peptide R&D, including drug discovery, safety and toxicology, clinical development, manufacturing, pharmaceutical development, formulation, drug delivery and regulatory affairs, the organization also provided 18 free speakers registration to the symposium.”
Form 990EZ, Part I, Line 16
“Accounting 713.”
Form 990EZ, Part I, Line 16
“Administration 18783.”
Form 990EZ, Part I, Line 16
“Subscriptions 180.”
Form 990EZ, Part I, Line 16
“Contract Services 921.”
Form 990EZ, Part I, Line 16
“Insurance 2300.”
Form 990EZ, Part I, Line 16
“License and Fess 1230.”
Form 990EZ, Part I, Line 16
“Bank Fees 112.”
Form 990EZ, Part I, Line 16
“Meals and Entertainment 79.”
Form 990EZ, Part I, Line 16
“Supplies 14.”
Form 990EZ, Part I, Line 16
“Other Costs 106.”
Form 990EZ, Part I, Line 16
“Symposium Expenses 120242.”
Form 990EZ, Part I, Line 20
“Unrealized gain on investments 18522.”
Raw XML Appendix182 raw XML fields
This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.
| Path | # | Value |
|---|---|---|
| IRS990EZ/ActivitiesNotPreviouslyRptInd | 0 | false |
| IRS990EZ/BooksInCareOfDetail/PersonNm | 0 | Blue Gum Advisors LLC |
| IRS990EZ/BooksInCareOfDetail/PhoneNum | 0 | 8586571511 |
| IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt | 0 | 3529 Bancroft St |
| IRS990EZ/BooksInCareOfDetail/USAddress/CityNm | 0 | San Diego |
| IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd | 0 | CA |
| IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd | 0 | 92104 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt | 0 | 286944 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt | 0 | 335263 |
| IRS990EZ/ChgMadeToOrgnzngDocNotRptInd | 0 | false |
| IRS990EZ/ContributionsGiftsGrantsEtcAmt | 0 | 0 |
| IRS990EZ/CostOfGoodsSoldAmt | 0 | 0 |
| IRS990EZ/CostOrOtherBasisExpenseSaleAmt | 0 | 0 |
| IRS990EZ/DonorAdvisedFndsInd | 0 | false |
| IRS990EZ/EngagedInExcessBenefitTransInd | 0 | false |
| IRS990EZ/ExcessOrDeficitForYearAmt | 0 | 29797 |
| IRS990EZ/FiledScheduleAInd | 0 | true |
| IRS990EZ/ForeignFinancialAccountInd | 0 | false |
| IRS990EZ/ForeignOfficeInd | 0 | false |
| IRS990EZ/Form1120PolFiledInd | 0 | false |
| IRS990EZ/Form990TotalAssetsGrp/BOYAmt | 0 | 286944 |
| IRS990EZ/Form990TotalAssetsGrp/EOYAmt | 0 | 335263 |
| IRS990EZ/FundraisingGrossIncomeAmt | 0 | 0 |
| IRS990EZ/GainOrLossFromSaleOfAssetsAmt | 0 | 0 |
| IRS990EZ/GrossProfitLossSlsOfInvntryAmt | 0 | 0 |
| IRS990EZ/GrossReceiptsAmt | 0 | 174477 |
| IRS990EZ/GrossReceiptsForPublicUseAmt | 0 | 0 |
| IRS990EZ/InfoInScheduleOPartIIIInd | 0 | X |
| IRS990EZ/InfoInScheduleOPartIInd | 0 | X |
| IRS990EZ/InitiationFeesAndCapContriAmt | 0 | 0 |
| IRS990EZ/InvestmentIncomeAmt | 0 | 0 |
| IRS990EZ/LobbyingActivitiesInd | 0 | false |
| IRS990EZ/MadeLoansToFromOfficersInd | 0 | false |
| IRS990EZ/MembershipDuesAmt | 0 | 174477 |
| IRS990EZ/MethodOfAccountingAccrualInd | 0 | X |
| IRS990EZ/NetAssetsOrFundBalancesBOYAmt | 0 | 286944 |
| IRS990EZ/NetAssetsOrFundBalancesEOYAmt | 0 | 335263 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt | 0 | 286944 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt | 0 | 335263 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 0 | 1.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 1 | 1.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 2 | 1.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 3 | 1.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 0 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 1 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 2 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 3 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt | 0 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt | 1 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt | 2 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt | 3 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt | 0 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt | 1 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt | 2 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt | 3 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 0 | Phil Dawson PHD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 1 | Adam Mezo PHD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 2 | Nick Cox PHD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 3 | Adrienne DAy PH D |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 0 | Chairman of Board |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 1 | President |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 2 | Secretary |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 3 | Treasurer & Board Administrator |
| IRS990EZ/OperateHospitalInd | 0 | false |
| IRS990EZ/Organization501c3Ind | 0 | X |
| IRS990EZ/OrganizationDissolvedEtcInd | 0 | false |
| IRS990EZ/OrganizationHadUBIInd | 0 | false |
| IRS990EZ/OtherChangesInNetAssetsAmt | 0 | 18522 |
| IRS990EZ/OtherExpensesTotalAmt | 0 | 144680 |
| IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt | 0 | NONE |
| IRS990EZ/PartVIOfCompOfHghstPdEmplTxt | 0 | NONE |
| IRS990EZ/PoliticalCampaignActyInd | 0 | false |
| IRS990EZ/PrimaryExemptPurposeTxt | 0 | The mission of Peptide Therapeutics Foundation is to provide and promote public and charitable educational and information programs, materials, research and discussion in the the medical scientific field of peptide science and technology. |
| IRS990EZ/ProgramServiceRevenueAmt | 0 | 0 |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt | 0 | see schedule O |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt | 1 | All other accomplishment. Peptide therapeutics has assets in an brokerage firm. Expenses are related to the brokerage firm. |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt | 0 | 0 |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt | 1 | 0 |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt | 0 | 142380 |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt | 1 | 2300 |
| IRS990EZ/ProhibitedTaxShelterTransInd | 0 | false |
| IRS990EZ/RelatedOrganizationCtrlEntInd | 0 | false |
| IRS990EZ/ScheduleBNotRequiredInd | 0 | X |
| IRS990EZ/SchoolOperatingInd | 0 | false |
| IRS990EZ/SpecialEventsDirectExpensesAmt | 0 | 0 |
| IRS990EZ/SpecialEventsNetIncomeLossAmt | 0 | 0 |
| IRS990EZ/SubjectToProxyTaxInd | 0 | false |
| IRS990EZ/TanningServicesProvidedInd | 0 | false |
| IRS990EZ/TotalExpensesAmt | 0 | 144680 |
| IRS990EZ/TotalProgramServiceExpensesAmt | 0 | 144680 |
| IRS990EZ/TotalRevenueAmt | 0 | 174477 |
| IRS990EZ/TransactionWithControlEntInd | 0 | false |
| IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd | 0 | false |
| IRS990EZ/TypeOfOrganizationCorpInd | 0 | X |
| IRS990EZ/WebsiteAddressTxt | 0 | WWW.peptidetherapeutics.org |
| IRS990ScheduleA/AmountsRcvdDsqlfyPersonGrp/TotalAmt | 0 | 0 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt | 0 | 50160 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt | 0 | 43680 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt | 0 | 93840 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt | 0 | 174477 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt | 0 | 134883 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt | 0 | 102509 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt | 0 | 20180 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus4YearsAmt | 0 | 6200 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt | 0 | 438249 |
| IRS990ScheduleA/GrossReceiptsNonUnrltBusGrp/TotalAmt | 0 | 0 |
| IRS990ScheduleA/InvestmentIncomeCYPct | 0 | 0.00000 |
| IRS990ScheduleA/OtherSupportSumAmt | 0 | 0 |
| IRS990ScheduleA/PubliclySupportedOrg509a2Ind | 0 | X |
| IRS990ScheduleA/PublicSupportCY170Pct | 0 | 0 |
| IRS990ScheduleA/PublicSupportCY509Pct | 0 | 1.00000 |
| IRS990ScheduleA/PublicSupportPY509Pct | 0 | 1.00000 |
| IRS990ScheduleA/PublicSupportTotal509Amt | 0 | 532089 |
| IRS990ScheduleA/SubstAndDsqlfyPrsnsTotGrp/TotalAmt | 0 | 0 |
| IRS990ScheduleA/SubstantialContributorsAmtGrp/TotalAmt | 0 | 0 |
| IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft509Grp/TotalAmt | 0 | 0 |
| IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind | 0 | X |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt | 0 | 174477 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt | 0 | 134883 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt | 0 | 102509 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt | 0 | 70340 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt | 0 | 49880 |
| IRS990ScheduleA/Total509Grp/TotalAmt | 0 | 532089 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt | 0 | 532089 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 0 | All other accomplishment. Peptide therapeutics has assets in an brokerage firm. Expenses are related to the brokerage firm. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 1 | Part III Line 28 Hold a peptide therapeutics symposium to bring together world leaders from academia, the biopharmaceutical industry, CMOS CROS,and investors interested in all aspects of peptide R&D, including drug discovery, safety and toxicology, clinical development, manufacturing, pharmaceutical development, formulation, drug delivery and regulatory affairs, the organization also provided 18 free speakers registration to the symposium. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 2 | Accounting 713. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 3 | Administration 18783. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 4 | Subscriptions 180. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 5 | Contract Services 921. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 6 | Insurance 2300. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 7 | License and Fess 1230. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 8 | Bank Fees 112. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 9 | Meals and Entertainment 79. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 10 | Supplies 14. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 11 | Other Costs 106. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 12 | Symposium Expenses 120242. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 13 | Unrealized gain on investments 18522. |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 0 | Pt III, Line 31 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 1 | Other |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 2 | Form 990EZ, Part I, Line 16 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 3 | Form 990EZ, Part I, Line 16 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 4 | Form 990EZ, Part I, Line 16 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 5 | Form 990EZ, Part I, Line 16 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 6 | Form 990EZ, Part I, Line 16 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 7 | Form 990EZ, Part I, Line 16 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 8 | Form 990EZ, Part I, Line 16 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 9 | Form 990EZ, Part I, Line 16 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 10 | Form 990EZ, Part I, Line 16 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 11 | Form 990EZ, Part I, Line 16 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 12 | Form 990EZ, Part I, Line 16 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 13 | Form 990EZ, Part I, Line 20 |
| ReturnHeader/BuildTS | 0 | 2025-03-06 01:10:19Z |
| ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd | 0 | true |
| ReturnHeader/BusinessOfficerGrp/PersonNm | 0 | Adrienne Day PHD |
| ReturnHeader/BusinessOfficerGrp/PersonTitleTxt | 0 | Treasurer&Board Dir |
| ReturnHeader/BusinessOfficerGrp/PhoneNum | 0 | 8586571511 |
| ReturnHeader/BusinessOfficerGrp/SignatureDt | 0 | 2025-01-29 |
| ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt | 0 | Peptide Therapeutics Foundation |
| ReturnHeader/Filer/BusinessNameControlTxt | 0 | PEPT |
| ReturnHeader/Filer/EIN | 0 | 263728931 |
| ReturnHeader/Filer/PhoneNum | 0 | 8586571511 |
| ReturnHeader/Filer/USAddress/AddressLine1Txt | 0 | 9395 Cabot Drive |
| ReturnHeader/Filer/USAddress/CityNm | 0 | San Diego |
| ReturnHeader/Filer/USAddress/StateAbbreviationCd | 0 | CA |
| ReturnHeader/Filer/USAddress/ZIPCd | 0 | 92126 |
| ReturnHeader/IRSResponsiblePrtyInfoCurrInd | 0 | true |
| ReturnHeader/PreparerFirmGrp/PreparerFirmEIN | 0 | 874161283 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt | 0 | V&R ASSOCIATES |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt | 0 | 4616 Tarantella Lane |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm | 0 | SD |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd | 0 | CA |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd | 0 | 92130 |
| ReturnHeader/PreparerPersonGrp/PhoneNum | 0 | 6198848983 |
| ReturnHeader/PreparerPersonGrp/PreparationDt | 0 | 2025-02-22 |
| ReturnHeader/PreparerPersonGrp/PreparerPersonNm | 0 | Viviane Hagopian |
| ReturnHeader/PreparerPersonGrp/SelfEmployedInd | 0 | X |
| ReturnHeader/ReturnTs | 0 | 2025-02-22T21:00:21-08:00 |
| ReturnHeader/ReturnTypeCd | 0 | 990EZ |
| ReturnHeader/TaxPeriodBeginDt | 0 | 2024-01-01 |
| ReturnHeader/TaxPeriodEndDt | 0 | 2024-12-31 |
| ReturnHeader/TaxYr | 0 | 2024 |
Document Assets
No mirrored PDF or thumbnail assets are attached yet.